Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of...

Area of Science:

• Genomics and Bioinformatics
• Neurodegenerative Diseases
• Molecular Biology

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive motor neuron disease with unknown mechanisms and limited therapeutic options.
• The lack of reliable biomarkers and effective treatments hinders prognosis and patient care for ALS.
• Sporadic ALS (sALS) represents the majority of cases, necessitating research into its specific molecular underpinnings.

Approach:

• Utilized bioinformatics analysis on the GEO GSE41414 dataset of sALS-affected muscle tissue.
• Identified 397 differentially expressed genes (DEGs) and performed functional enrichment analysis.
• Constructed protein-protein interaction and miRNA target gene networks to identify key molecular players.

Key Points:

• 320 up-regulated DEGs were linked to muscle development, while 77 down-regulated DEGs were associated with energy metabolism.
• Identified 20 hub genes, including EIF4A1, HNRNPR, and NDUFA4, through network analysis.
• Discovered 17 miRNAs targeting hub genes, with hsa-mir-206, hsa-mir-133b, and hsa-mir-100-5p previously implicated in ALS.

Conclusions:

• This study proposes novel potential biomarkers for ALS diagnosis and prognosis.
• Identified potential therapeutic targets for future ALS drug development.
• Correlating bioinformatics findings with literature review provides a foundation for further ALS research.